Sunshine Guojian Pharmaceutical Shanghai Co Ltd banner
S

Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336

Watchlist Manager
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Watchlist
Price: 70.03 CNY 23.14% Market Closed
Market Cap: ¥43.3B

Wall Street
Price Targets

Price Targets Summary
Sunshine Guojian Pharmaceutical Shanghai Co Ltd

Wall Street analysts forecast Sunshine Guojian Pharmaceutical Shanghai Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sunshine Guojian Pharmaceutical Shanghai Co Ltd is 76.77 CNY with a low forecast of 73.69 CNY and a high forecast of 81.44 CNY.

Lowest
Price Target
73.69 CNY
5% Upside
Average
Price Target
76.77 CNY
10% Upside
Highest
Price Target
81.44 CNY
16% Upside
Sunshine Guojian Pharmaceutical Shanghai Co Ltd Competitors:
Price Targets
WLFC
Willis Lease Finance Corp
-4% Downside
VAC
Pierre et Vacances SA
36% Upside
NCSM
NCS Multistage Holdings Inc
-26% Downside

Revenue
Forecast

1% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
1% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

For the last 6 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's revenue is 1%. The projected CAGR for the next 3 years is 15%.

Operating Income
Forecast

-7% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
N/A
Average
-7% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
N/A
Average

For the last 6 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's operating income is -7%. The projected CAGR for the next 3 years is 39%.

Net Income
Forecast

11% / Year
Past Growth
-8% / Year
Estimated Growth
Estimates Accuracy
N/A
Average
11% / Year
Past Growth
-8% / Year
Estimated Growth
Estimates Accuracy
N/A
Average

For the last 6 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's net income is 11%. The projected CAGR for the next 3 years is -8%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd's stock price target?
Price Target
76.77 CNY

According to Wall Street analysts, the average 1-year price target for Sunshine Guojian Pharmaceutical Shanghai Co Ltd is 76.77 CNY with a low forecast of 73.69 CNY and a high forecast of 81.44 CNY.

What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd's Revenue forecast?
Projected CAGR
15%

For the last 6 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's revenue is 1%. The projected CAGR for the next 3 years is 15%.

What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd's Operating Income forecast?
Projected CAGR
39%

For the last 6 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's operating income is -7%. The projected CAGR for the next 3 years is 39%.

What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd's Net Income forecast?
Projected CAGR
-8%

For the last 6 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's net income is 11%. The projected CAGR for the next 3 years is -8%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett